Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Amyloid Fibrils03:03

Amyloid Fibrils

10.2K
Amyloid fibrils are aggregates of misfolded proteins.  Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils. 
Amyloid deposits were observed as early as 1639 in the liver and the spleen.   In 1854, Rudolph Virchow performed iodine staining,...
10.2K
Microbial Interactions: Parasitism01:22

Microbial Interactions: Parasitism

108
Parasitism is a form of microbial interaction in which parasitic microbes exploit a host organism for nutrients and shelter, often at the host's expense. Unlike mutualistic relationships, where both organisms benefit, parasitism benefits only the parasite and harms the host.Classification of ParasitesMicrobial parasites are broadly classified based on their location relative to the host.Ectoparasites remain on the host’s surface, such as the skin or outer tissues, drawing nutrients...
108
Fungal Phylum Microsporidia01:28

Fungal Phylum Microsporidia

782
Microsporidia are a group of obligate intracellular fungi that were initially classified as protists but were later reclassified based on phylogenetic, molecular, and structural evidence linking them to the Chytridiomycota. These unicellular, non-motile organisms are highly specialized parasites that infect a wide range of animal hosts, including humans. They have evolved extensive genomic and metabolic reductions, making them highly dependent on their hosts for survival.Morphology and Genomic...
782

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Leveraging the dominant-negative effect of the kuru-protective G127V prion protein variant as a novel therapeutic strategy.

Neurobiology of disease·2026
Same author

Distinct prion conformers from brain and peripheral tissues of gene-targeted mice produce convergent CWD strain properties.

PLoS pathogens·2026
Same author

Incomplete protection of the K<sub>222</sub> polymorphism of the prion protein gene after intracerebral exposure to caprine BSE in goats: preliminary follow-up in S<sub>127</sub> carriers.

Veterinary research·2026
Same author

A model-based prion vaccine protects a transgenic mouse line carrying a Gerstmann-Sträussler-Scheinker disease mutation.

Acta neuropathologica·2026
Same author

Quadriceps mitochondrial DNA quantity, quality, and gene expression after 2 years of calorie restriction: exploratory results from the CALERIE trial.

GeroScience·2026
Same author

Leveraging the dominant-negative effect of the kuru-protective G127V prion protein variant as a novel therapeutic strategy.

bioRxiv : the preprint server for biology·2026

Related Experiment Video

Updated: May 4, 2026

Protein Misfolding Cyclic Amplification of Prions
10:12

Protein Misfolding Cyclic Amplification of Prions

Published on: November 7, 2012

18.8K

Prion disease tempo determined by host-dependent substrate reduction.

Charles E Mays, Chae Kim, Tracy Haldiman

    The Journal of Clinical Investigation
    |January 17, 2014
    PubMed
    Summary

    Prion diseases involve misfolded prion protein (PrPSc) accumulation. This study reveals that cellular prion protein (PrPC) reduction occurs in various prion infections, impacting disease progression and offering a new therapeutic target.

    More Related Videos

    Assessing Transmissible Spongiform Encephalopathy Species Barriers with an In Vitro Prion Protein Conversion Assay
    11:41

    Assessing Transmissible Spongiform Encephalopathy Species Barriers with an In Vitro Prion Protein Conversion Assay

    Published on: March 10, 2015

    7.2K
    High-throughput Screening for Protein-based Inheritance in S. cerevisiae
    08:12

    High-throughput Screening for Protein-based Inheritance in S. cerevisiae

    Published on: August 8, 2017

    5.9K

    Related Experiment Videos

    Last Updated: May 4, 2026

    Protein Misfolding Cyclic Amplification of Prions
    10:12

    Protein Misfolding Cyclic Amplification of Prions

    Published on: November 7, 2012

    18.8K
    Assessing Transmissible Spongiform Encephalopathy Species Barriers with an In Vitro Prion Protein Conversion Assay
    11:41

    Assessing Transmissible Spongiform Encephalopathy Species Barriers with an In Vitro Prion Protein Conversion Assay

    Published on: March 10, 2015

    7.2K
    High-throughput Screening for Protein-based Inheritance in S. cerevisiae
    08:12

    High-throughput Screening for Protein-based Inheritance in S. cerevisiae

    Published on: August 8, 2017

    5.9K

    Area of Science:

    • Neuroscience
    • Molecular Biology
    • Infectious Diseases

    Background:

    • Prion diseases are characterized by the accumulation of misfolded prion protein (PrPSc).
    • The cellular precursor, PrPC, and Shadoo (Sho) glycoprotein share cellular environments, suggesting PrPC levels might also change during prion infection.
    • Prion disease symptoms manifest years after exposure, indicating a long presymptomatic period.

    Purpose of the Study:

    • To investigate alterations in cellular prion protein (PrPC) levels during prion infection.
    • To determine if PrPC reduction impacts prion replication and disease pathogenesis.
    • To identify potential molecular markers and therapeutic targets for prion diseases.

    Main Methods:

    • Rodent models of prion infection were utilized.
    • Changes in PrPC glycosylation and proteolytic processing were analyzed.
    • Prion replication was measured using the protein misfolding cyclic amplification (PMCA) technique.

    Main Results:

    • Net reductions in PrPC were observed across various prion diseases, including sheep scrapie, human Creutzfeldt-Jakob disease, and cervid chronic wasting disease.
    • Reduced PrPC levels correlated with decreased prion replication in vitro.
    • PrPC downregulation was evident in slowly evolving prion infections, affecting PrPSc synthesis and pathogenic signaling.

    Conclusions:

    • PrPC downregulation is a significant, previously unrecognized factor in prion disease pathogenesis.
    • Reduced PrPC levels contribute to the extended presymptomatic phase of prion infections.
    • Targeting PrPC reduction may offer a novel therapeutic strategy for prion diseases.